These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15313766)

  • 1. Beta-blocker-induced quadriparesis.
    Izzedine H; Launay-Vacher V; Hulot JS; Sternberg D; Deray G
    Ann Intern Med; 2004 Aug; 141(4):W62. PubMed ID: 15313766
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
    Galatius S; Gustafsson F; Atar D; Hildebrandt PR
    Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
    Taniguchi T; Ohtani T; Mizote I; Kanzaki M; Ichibori Y; Minamiguchi H; Asano Y; Sakata Y; Komuro I
    J Cardiol; 2013 Jun; 61(6):417-22. PubMed ID: 23548374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol Associated Hypoglycemia in a Diabetic Patient on Maintenance Hemodialysis.
    Maekawa M; Takahashi A; Miki Y
    Ther Apher Dial; 2017 Oct; 21(5):513-514. PubMed ID: 28524584
    [No Abstract]   [Full Text] [Related]  

  • 7. Carvedilol-induced myoclonus.
    Fernandez HH; Friedman JH
    Mov Disord; 1999 Jul; 14(4):703. PubMed ID: 10435516
    [No Abstract]   [Full Text] [Related]  

  • 8. Peyronie disease in association with carvedilol: a case report.
    Bell DS
    South Med J; 2008 Nov; 101(11):1157-8. PubMed ID: 19088529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
    Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L;
    Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible adverse skin reaction to carvedilol.
    Simpson SH; Tsuyuki RT; Gutierrez R; Lo A; Teo KK
    Can J Cardiol; 1998 Oct; 14(10):1277-9. PubMed ID: 9852941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous vasculitis induced by carvedilol.
    Pavlović MD; Dragojević Simić V; Zolotarevski L; Zecević RD; Vesić S
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):1004-5. PubMed ID: 17659030
    [No Abstract]   [Full Text] [Related]  

  • 13. Carvedilol outclasses the other beta-blockers.
    Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696
    [No Abstract]   [Full Text] [Related]  

  • 14. Carvedilol does not modulate moderate exercise-induced hyperkalemia in hemodialysis patients.
    Nowicki M; Szewczyk-Seifert G; Klimek D; Kokot F
    Clin Nephrol; 2002 May; 57(5):352-8. PubMed ID: 12036194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol for heart failure, with care.
    Cleland JG; Swedberg K
    Lancet; 1996 May; 347(9010):1199-201. PubMed ID: 8622445
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of drug-induced pneumonitis caused by carvedilol.
    Markou N; Antzoulatos N; Haniotou A; Kanakaki M; Parissis J; Damianos A
    Respiration; 2004; 71(6):650-2. PubMed ID: 15627880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure?
    Rohrer CK; Page RL; Shakar SF; Lindenfeld J
    J Card Fail; 2011 Oct; 17(10):875-7. PubMed ID: 21962427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carvedilol on seizure induction during electroconvulsive therapy procedure.
    Syed N
    J ECT; 2009 Mar; 25(1):60. PubMed ID: 18978602
    [No Abstract]   [Full Text] [Related]  

  • 19. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.
    Miró Ò; Müller C; Martín-Sánchez FJ; Bueno H; Mebazaa A; Herrero P; Jacob J; Gil V; Escoda R; Llorens P;
    Clin Res Cardiol; 2016 Dec; 105(12):1021-1029. PubMed ID: 27379611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.